Insider · CIK 0001557930

Erbez Georgia

Reports to the SEC for 8 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001557930

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-23	CDXSCODEXIS, INC. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+316K sh	—	—	316,100
2026-02-06	CDXSCODEXIS, INC.S Sale	See Remarks	SSale	−3,826 sh	$1.31	−$5,000.965	66,810
2025-10-13	CDXSCODEXIS, INC.S Sale	See Remarks	SSale	−6,239 sh	$2.50	−$15.6K	70,636
2025-06-12	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+112K sh	—	—	112,000
2025-02-05	CDXSCODEXIS, INC.A Award	See Remarks	AAward	+26.9K sh	—	—	76,875
2025-02-05	CDXSCODEXIS, INC. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+161K sh	—	—	161,250
2024-10-10	CDXSCODEXIS, INC. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+300K sh	—	—	300,000
2024-10-10	CDXSCODEXIS, INC.A Award	See Remarks	AAward	+50K sh	—	—	50,000
2024-06-04	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+114K sh	—	—	114,000
2024-02-20	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+54K sh	—	—	54,000
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18K sh	—	—	0
2022-01-28	Harpoon Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+115K sh	—	—	115,000
2021-11-11	Harpoon Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+115K sh	—	—	115,000
2021-09-22	Harpoon Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+10.3K sh	$8.10	+$83.4K	19,215
2021-06-02	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2021-02-17	Harpoon Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−25K sh	—	—	145,908
2021-02-17	Harpoon Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+25K sh	$2.12	+$53K	72,292
2021-01-28	Harpoon Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+72K sh	—	—	72,000
2020-08-19	Harpoon Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$11.40	+$57K	8,915
2020-08-18	Harpoon Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,098 sh	$11.60	+$24.3K	3,915
2020-07-31	Harpoon Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+1,817 sh	$10.92	+$19.8K	1,817
2020-01-31	Harpoon Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+52.2K sh	—	—	52,160
2020-01-21	Harpoon Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+6,700 sh	$14.09	+$94.4K	6,700
2019-12-04	Harpoon Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−47.3K sh	—	—	170,908
2019-12-04	Harpoon Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+47.3K sh	$2.12	+$100K	47,292
2019-08-29	ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+22.3K sh	—	—	22,250
2017-05-25	Zosano Pharma CorpP Purchase	CFO and Chief Business Officer	PPurchase	+68K sh	$1.32	+$89.8K	115,750
2016-09-07	Zosano Pharma CorpStock Option (right to buy)A Award	CFO and Chief Business Officer	AAward	+252K sh	—	—	252,000
2016-08-19	Zosano Pharma CorpSeries B Warrants (right to buy)P Purchase	CFO and Chief Business Officer	PPurchase	+47.8K sh	$0.13	+$5,968.75	47,750
2016-08-19	Zosano Pharma CorpP Purchase	CFO and Chief Business Officer	PPurchase	+47.8K sh	$1.32	+$63K	47,750
2016-08-19	Zosano Pharma CorpSeries A Warrants (right to buy)P Purchase	CFO and Chief Business Officer	PPurchase	+47.8K sh	$0.13	+$5,968.75	47,750
2015-11-09	Asterias Biotherapeutics, Inc.Stock Options (right to buy)A Award	Exec VP & CFO	AAward	+380K sh	—	—	380,000
2014-02-07	HORIZON PHARMACEUTICAL LLCStock options (right to buy)A Award	Chief Financial Officer	AAward	+83.8K sh	—	—	83,800
2013-08-30	HORIZON PHARMACEUTICAL LLCS Sale	Chief Financial Officer	SSale	−1,981 sh	$13.42	−$26.6K	519
2013-08-30	HORIZON PHARMACEUTICAL LLCS Sale	Chief Financial Officer	SSale	−4,900 sh	$13.42	−$65.8K	2,500
2013-08-30	HORIZON PHARMACEUTICAL LLCS Sale	Chief Financial Officer	SSale	−519 sh	$13.43	−$6,970.689	0
2012-09-10	HORIZON PHARMACEUTICAL LLCStock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+190K sh	—	—	190,000

Recent filings

Accepted (ET)
Feb 254
Erbez Georgia0001610717-26-000071
SEC(opens sec.gov)
Feb 94
Erbez Georgia0001610717-26-000046
SEC(opens sec.gov)
Oct 154
Erbez Georgia0001610717-25-000362
SEC(opens sec.gov)
Jun 134
Erbez Georgia0001610717-25-000224
SEC(opens sec.gov)
Feb 74
Erbez Georgia0000905148-25-000440
SEC(opens sec.gov)
Oct 104
Erbez Georgia0000905148-24-002705
SEC(opens sec.gov)
Jun 54
Erbez Georgia0001610717-24-000293
SEC(opens sec.gov)
Feb 224
Erbez Georgia0001610717-24-000088
SEC(opens sec.gov)
Jul 14
Erbez Georgia0001209191-22-040229
SEC(opens sec.gov)
Feb 14
Erbez Georgia0001209191-22-005885
SEC(opens sec.gov)
Nov 154
Erbez Georgia0001209191-21-064440
SEC(opens sec.gov)
Sep 224
Erbez Georgia0001209191-21-057342
SEC(opens sec.gov)
Jun 44
Erbez Georgia0001209191-21-038129
SEC(opens sec.gov)
Feb 184
Erbez Georgia0001209191-21-011626
SEC(opens sec.gov)
Jan 294
Erbez Georgia0001209191-21-006304
SEC(opens sec.gov)
Aug 204
Erbez Georgia0001209191-20-047804
SEC(opens sec.gov)

Companies

Address

C/O CODEXIS, INC. 200 PENOBSCOT DRIVE

REDWOOD CITY, CA, 94063